Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yasushi Isobe

Showing results (41-50 of 67) with videos related to

Pageof 7
Sort By:
Cancer Science|January 25, 2018
Expression of activating natural killer-cell receptors is a hallmark of the innate-like T-cell neoplasm in peripheral T-cell lymphomasYu Uemura, Yasushi Isobe, Akiko Uchida, et al.
International Journal of Hematology|May 20, 2009
Absence of tumor-specific over-expression of Polo-like kinase 1 (Plk1) in major non-Hodgkin lymphoma and relatively low expression of Plk1 in nasal NK/T cell lymphomaHidenori Imai, Koichi Sugimoto, Yasushi Isobe, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|March 10, 2020
[Leukemic cell kinetics of APL with a novel complex variant t (12;17;15)(p13;q21;q22)]Yusuke Saiki, Hirotaka Sakai, Akiko Uchida, et al.
Cancer Science|September 3, 2015
A clinically attainable dose of L-asparaginase targets glutamine addiction in lymphoid cell linesKoichi Sugimoto, Hiroshi I Suzuki, Tsutomu Fujimura, et al.
Internal Medicine (Tokyo, Japan)|May 16, 2009
Analysis of triglyceride value in the diagnosis and treatment response of secondary hemophagocytic syndromeMuneo Okamoto, Hiroki Yamaguchi, Yasushi Isobe, et al.
Thrombosis Research|September 21, 2013
Recombinant thrombomodulin improved Stevens-Johnson syndrome with high serum high-mobility group-B1 DNA-binding protein induced by lenalidomide administered to treat multiple myelomaYasuyuki Inoue, Tasuku Saito, Yuka Tsuruoka, et al.
International Journal of Cancer|December 21, 2010
Bortezomib induces apoptosis in T lymphoma cells and natural killer lymphoma cells independent of Epstein-Barr virus infectionSeiko Iwata, Shoko Yano, Yoshinori Ito, et al.
International Journal of Hematology|October 28, 2008
Current and future perspectives on the TARGET system: the registration system for Glivec established by the JSHMasahiro Kizaki, Shinichiro Okamoto, Tetsuzo Tauchi, et al.
International Journal of Hematology|January 31, 2015
PAX5-positive plasma cell myeloma with t(9;14;11)(p13;q32;q13), a novel complex variant translocation of t(11;14)(q13;q32) and t(9;14)(p13;q32)Kazuyuki Sato, Hirotaka Sakai, Masayuki Kato, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|February 14, 2017
Acute myeloid leukemia with t(3;21)(q13;q22), a novel simple variant of the 21q22/RUNX1 translocationYuka Tsuruoka, Hirotaka Sakai, Akiko Uchida, et al.
Pageof 7

Showing results (41-50 of 67) with videos related to

Sort By:
Pageof 7
Cancer Science|January 25, 2018
Expression of activating natural killer-cell receptors is a hallmark of the innate-like T-cell neoplasm in peripheral T-cell lymphomasYu Uemura, Yasushi Isobe, Akiko Uchida, et al.
International Journal of Hematology|May 20, 2009
Absence of tumor-specific over-expression of Polo-like kinase 1 (Plk1) in major non-Hodgkin lymphoma and relatively low expression of Plk1 in nasal NK/T cell lymphomaHidenori Imai, Koichi Sugimoto, Yasushi Isobe, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|March 10, 2020
[Leukemic cell kinetics of APL with a novel complex variant t (12;17;15)(p13;q21;q22)]Yusuke Saiki, Hirotaka Sakai, Akiko Uchida, et al.
Cancer Science|September 3, 2015
A clinically attainable dose of L-asparaginase targets glutamine addiction in lymphoid cell linesKoichi Sugimoto, Hiroshi I Suzuki, Tsutomu Fujimura, et al.
Internal Medicine (Tokyo, Japan)|May 16, 2009
Analysis of triglyceride value in the diagnosis and treatment response of secondary hemophagocytic syndromeMuneo Okamoto, Hiroki Yamaguchi, Yasushi Isobe, et al.
Thrombosis Research|September 21, 2013
Recombinant thrombomodulin improved Stevens-Johnson syndrome with high serum high-mobility group-B1 DNA-binding protein induced by lenalidomide administered to treat multiple myelomaYasuyuki Inoue, Tasuku Saito, Yuka Tsuruoka, et al.
International Journal of Cancer|December 21, 2010
Bortezomib induces apoptosis in T lymphoma cells and natural killer lymphoma cells independent of Epstein-Barr virus infectionSeiko Iwata, Shoko Yano, Yoshinori Ito, et al.
International Journal of Hematology|October 28, 2008
Current and future perspectives on the TARGET system: the registration system for Glivec established by the JSHMasahiro Kizaki, Shinichiro Okamoto, Tetsuzo Tauchi, et al.
International Journal of Hematology|January 31, 2015
PAX5-positive plasma cell myeloma with t(9;14;11)(p13;q32;q13), a novel complex variant translocation of t(11;14)(q13;q32) and t(9;14)(p13;q32)Kazuyuki Sato, Hirotaka Sakai, Masayuki Kato, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|February 14, 2017
Acute myeloid leukemia with t(3;21)(q13;q22), a novel simple variant of the 21q22/RUNX1 translocationYuka Tsuruoka, Hirotaka Sakai, Akiko Uchida, et al.
Pageof 7